Trieu Vuong - Insider Non-Derivative Transactions at Oncotelic Therapeutics, Inc. (OTLC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 10, 2025, Trieu Vuong's relationship to Oncotelic Therapeutics, Inc. (OTLC) is Director,Officer,TenPercentOwner (CHAIRMAN AND CEO), and currently has 93,293,560 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OTLC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Trieu Vuong - Insider Non-Derivative Transactions of OTLC Common Stock

Trieu Vuong - Insider Non-Derivative Transactions at OTLC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 11, 2025	P -- (Common Stock)	104000	0.01	93293560
Jul 10, 2025	P -- (Common Stock)	1	0.01	93293561
Jul 9, 2025	P -- (Common Stock)	94736	0.01	93388297
Feb 1, 2025	P -- (Common Stock)	63775	0.03	93189560
Jan 31, 2025	P -- (Common Stock)	100003	0.03	93125785
Jan 30, 2025	P -- (Common Stock)	183066	0.03	93025782
Nov 23, 2024	P -- (Common Stock)	298499	0.03	92842716
Aug 24, 2024	P -- (Common Stock)	500000	0.02	92544217
Jun 30, 2023	P -- (Common Stock)	425000	0.02	92044217
Jun 29, 2023	P -- (Common Stock)	75000	0.03	91619217
Jun 17, 2023	P -- (Common Stock)	100000	0.03	91544217
Jun 15, 2023	P -- (Common Stock)	400000	0.03	91444217
May 27, 2023	P -- (Common Stock)	126888	0.03	91044217
May 3, 2023	P -- (Common Stock)	100000	0.05	90917329